Name | Cvs Pharmacy #10424 |
---|---|
Organization Name | Utah Cvs Pharmacy Llc |
Location | 5557 W 4100 S, West Valley City, Utah 84120 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Phone | (801) 966-1118 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
According to a new study in the journal Heliyon, published by Elsevier, dysfunctional eating patterns and habits in overweight and obese adults can be triggered by early life experiences that are deeply rooted within patients' personality features.
Researchers have generally believed that teachers are better than parents at evaluating the behavior of school children, because teachers have a bigger group of children for comparison.
OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.
› Verified 5 days ago
NPI Number | 1124475108 |
Organization Name | UTAH CVS PHARMACY, L.L.C. |
Doing Business As | CVS PHARMACY # 10424 |
Type | Durable Medical Equipment & Medical Supplies Supplier |
Address | 5557 W 4100 S, West Valley City, UT 84120 |
Phone Number | 801-966-1118 |
News Archive
A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
According to a new study in the journal Heliyon, published by Elsevier, dysfunctional eating patterns and habits in overweight and obese adults can be triggered by early life experiences that are deeply rooted within patients' personality features.
Researchers have generally believed that teachers are better than parents at evaluating the behavior of school children, because teachers have a bigger group of children for comparison.
OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.
› Verified 5 days ago
News Archive
A chemically altered form of vitamin E mixed into mouse chow dramatically reduced spread of aggressive mammary cancer in mice, suggesting that the compound in pill form could be used to treat human metastatic cancer, according to a report in the October 1 issue of the journal Cancer Research.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
According to a new study in the journal Heliyon, published by Elsevier, dysfunctional eating patterns and habits in overweight and obese adults can be triggered by early life experiences that are deeply rooted within patients' personality features.
Researchers have generally believed that teachers are better than parents at evaluating the behavior of school children, because teachers have a bigger group of children for comparison.
OrbusNeich today announced at the Transcatheter Cardiovascular Therapeutics (TCT) 2010 in Washington the completion of patient enrollment in the randomized clinical trial of the Combo Bio-engineered Sirolimus Eluting Stent (Combo Stent) with 183 patients included at sites in Asia, Australia, Europe and South America.
› Verified 5 days ago
Generational Health Llc Type: Medicare Supplier Location: 1264 W Village Main Dr, West Valley City, Utah 84119 Phone: (801) 972-0393 | |
Harmons Pharmacy #01 Type: Community/Retail Pharmacy Location: 3955 W 3500 S, West Valley City, Utah 84120 Phone: (801) 966-1497 | |
Otto Bock Orthopedic Services Llc Type: Medicare Supplier Location: 2875 S Decker Lake Dr, West Valley City, Utah 84119 Phone: (801) 974-6650 | |
Smiths Pharmacy #137 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4643 S 4000 W, West Valley City, Utah 84120 Phone: (801) 968-1896 | |
Numotion Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2305 S Presidents Dr, West Valley City, Utah 84120 Phone: (385) 743-2325 |